with p53 mutations and deletions Alemtuzumab is an effective therapy for chronic lymphocytic leukemia

doi:10.1182/blood-2003-10-3729Prepublished online January 15, 2004;2004 103: 3278-3281€€€€Michael R. Grever and John C. ByrdMollie Moran, Margaret Lucas, Thomas Lin, Marcy L. Hackbarth, John H. Proffitt, David Lucas, Gerard Lozanski, Nyla A. Heerema, Ian W. Flinn, Lisa Smith, Jennifer Harbison, Jennifer Webb,€